Dual Inhibition of Mitogen-Activated Protein Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer

Documenti analoghi

• Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
  di: Jin, Ning, et al.
  Pubblicazione: (2009)
• Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
  di: Jin, Ning, et al.
  Pubblicazione: (2009)
• Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancers
  di: Schweppe, Rebecca E., et al.
  Pubblicazione: (2009)
• Mammalian target of rapamycin inhibition in hepatocellular carcinoma
  di: Ashworth, René E, et al.
  Pubblicazione: (2014)
• Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma
  di: Gao, Ju, et al.
  Pubblicazione: (2013)